• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: Colchicine
Date Designated: 12/09/1985
Orphan Designation: For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis.
Orphan Designation Status: Designated/Withdrawn
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Pharmacontrol Corporation
661 Palisade Ave., P.O. Box 931
Englewood Cliffs, New Jersey 07632
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.